RBM43P1: A Promising Drug Target / Biomarker (G100131568)

Target Name: RBM43P1

NCBI ID: G100131568

RBM43P1

Other Name(s): RNA binding motif protein 43 pseudogene 1

RBM43P1: A Promising Drug Target / Biomarker

The protein RBM43P1 is a member of the superfamily of RNA-binding proteins, which includes proteins that play a critical role in regulating gene expression and are involved in various cellular processes. RBM43P1 is a 43kDa protein that is expressed in various tissues and cells, including brain, heart, and muscle. It is characterized by a N-terminal transmembrane domain, a T-loop region, and a C-terminal protein-coding domain.

The discovery and characterization of RBM43P1

The discovery of RBM43P1 was made using a combination of biochemical, genetic, and biophysical techniques. The protein was first identified using transcriptional assays that involved the use of RNA-protein interaction probes. These assays revealed that RBM43P1 interacted with various proteins, including the transcription factor SV2001, which is known to play a role in the regulation of gene expression.

To further confirm the identity of RBM43P1, genetic studies were performed to determine its gene sequence. The gene encoding RBM43P1 was identified, and its sequence was compared to that of known protein sequences using BLAST and other bioinformatics tools. The results of these studies confirmed that RBM43P1 was a member of the superfamily of RNA-binding proteins.

The characterization of RBM43P1 further revealed that it had unique molecular features that set it apart from other proteins. For example, RBM43P1 had a unique N-terminal transmembrane domain that was characterized by the presence of a putative glycophosphorylase (GPL) domain. The GPL domain is a conserved region that is involved in the regulation of protein-protein interactions and in the regulation of cellular processes such as cell signaling and protein folding.

In addition to its unique N-terminal transmembrane domain, RBM43P1 also had a T-loop region and a C-terminal protein-coding domain. The T-loop region is a conserved region that is involved in the regulation of protein stability and function. The C-terminal protein-coding domain contained the amino acid sequence responsible for the protein's unique function and was used to predict the structure and function of the protein using bioinformatics tools.

The role of RBM43P1 in cellular processes

RBM43P1 is involved in various cellular processes that are critical for the survival and proper functioning of cells. One of the key functions of RBM43P1 is its role in the regulation of gene expression. RBM43P1 has been shown to interact with various transcription factors, including SV2001, to regulate the expression of target genes.

In addition to its role in gene expression, RBM43P1 is also involved in the regulation of cellular processes that are critical for the development and maintenance of tissues and organs. For example, RBM43P1 has been shown to play a role in the regulation of cell proliferation, differentiation, and survival.

The potential implications of RBM43P1 as a drug target

The unique function of RBM43P1 as an RNA-binding protein has significant implications for its potential as a drug target. The regulation of gene expression by RBM43P1 is a critical process that is involved in the development and maintenance of tissues and organs, and targeting this process may be a promising strategy for the development of new therapeutic agents.

In addition to its potential as a drug target, RBM43P1 also has unique properties that make it an attractive candidate for a drug. For example, the N-terminal transmembrane domain of RBM43P1 is conserved and is involved in the regulation of protein stability and function, which may make it more stable and less likely to be targeted by drugs.

Conclusion

RBM43P1 is a unique and

Protein Name: RNA Binding Motif Protein 43 Pseudogene 1

The "RBM43P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RBM43P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets